All Updates

All Updates

icon
Filter
Earnings/results
Maple Leaf Foods to change its investment approach for its plant-based meat business in response to declining sales
Plant-based Meat
Feb 24, 2022
This week:
Funding
EKORE raises EUR 1.3 million (~ USD 1 million) in seed funding to strengthen platform
Digital Twin
Dec 20, 2024
Funding
Culina Health raises USD 7.9 million in Series A funding to expand offerings and expand team
Functional Nutrition
Dec 19, 2024
FDA approval
ViGeneron receives IND clearance for VG801 gene therapy
Cell & Gene Therapy
Dec 19, 2024
Product updates
Reflex Aerospace ships first commercial satellite SIGI
Next-gen Satellites
Dec 19, 2024
Partnerships
Vast partners with SpaceX for two private astronaut missions to ISS
Space Travel and Exploration Tech
Dec 19, 2024
Management news
Carbios appoints Philippe Pouletty as interim CEO amid plant delay
Waste Recovery & Management Tech
Dec 19, 2024
Funding
BlueQubit raises USD 10 million in seed funding to develop quantum platform
Quantum Computing
Dec 19, 2024
FDA approval
Arbor Biotechnologies receives FDA clearance for ABO-101 IND application
Human Gene Editing
Dec 19, 2024
Funding
Partnerships
Personalis partners with Merck and Moderna for cancer therapy development and investment
Precision Medicine
Dec 19, 2024
Partnerships
COTA partners with Guardant Health to develop clinicogenomic data solutions for cancer research
Precision Medicine
Dec 19, 2024
Plant-based Meat

Plant-based Meat

Feb 24, 2022

Maple Leaf Foods to change its investment approach for its plant-based meat business in response to declining sales

Earnings/results

  • Maple Leaf, a leading Canadian food processor, reported a 12.7% YoY dip in revenue (down 6.4% YoY excluding the forex impact) to CAD 184.1 million (~USD 144.0 million) in FY2021 for its plant-based meat segment, Plant Protein Group. The segment, which includes the Lightlife and Field Roast brands, was hampered by lower retail product volumes as well as the impact of an extra week in the fourth quarter of 2020, partially offset by growth in food service volumes and pricing action implemented in 3Q2021.

  • Plant Protein Group’s gross profit for FY2021 was in the red at a negative CAD 12.8 million (~USD 10.0 million) vs gross profit of CAD18.3 million (~USD 14.3 million) a year ago, translating to a margin of -7.0% (vs 8.7% for FY2020). Lower sales volumes and increased overhead and transitory costs due to strategic investments in capacity to build for anticipated demand as well as inflationary pressures on distribution and other input costs negatively impacted the business segment’s gross profit.

  • The company believes that given the current consumer feedback, experience, buy rates, and home penetration, the high category growth rates originally forecast by many industry experts are unlikely to be attained. However, Maple Leaf expects its plant-based food segment to grow at a modest yet attractive pace with current estimates suggesting an annual average rate of 10%–15%, making a CAD 6 billion to CAD 10 billion market by 2030. As a result, the company is pivoting its Plant Protein Group strategy and investment thesis, with a new aim of delivering neutral or better adjusted EBITDA over the next 18 months. The plan to support this shift is still ongoing and the company will make revisions to its investment thesis to match with the market opportunity.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.